Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000831547-23-000012
Filing Date
2023-05-11
Accepted
2023-05-11 16:03:03
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sppi-20230331.htm   iXBRL 10-Q 1242403
2 EX-31.1 sppi20230331ex311.htm EX-31.1 10002
3 EX-31.2 sppi20230331ex312.htm EX-31.2 10021
4 EX-32.1 sppi20230331ex321.htm EX-32.1 5957
5 EX-32.2 sppi20230331ex322.htm EX-32.2 5973
11 sppi-20230331_g1.jpg GRAPHIC 56984
  Complete submission text file 0000831547-23-000012.txt   6798880

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sppi-20230331.xsd EX-101.SCH 44270
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sppi-20230331_cal.xml EX-101.CAL 73645
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sppi-20230331_def.xml EX-101.DEF 203285
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sppi-20230331_lab.xml EX-101.LAB 640503
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sppi-20230331_pre.xml EX-101.PRE 390370
57 EXTRACTED XBRL INSTANCE DOCUMENT sppi-20230331_htm.xml XML 1023855
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filer) CIK: 0000831547 (see all company filings)

EIN.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35006 | Film No.: 23910833
SIC: 2834 Pharmaceutical Preparations